Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins

Oncolytic herpes simplex viruses (oHSVs) have been approved for clinical usage and become more and more popular for tumor virotherapy. However, there are still many issues for the oHSVs used in clinics and clinical trials. The main issues are the limited anti-tumor effects, intratumor injection, and...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Xiao-Qin Liu (Автор), Hong-Yi Xin (Автор), Yan-Ning Lyu (Автор), Zhao-Wu Ma (Автор), Xiao-Chun Peng (Автор), Ying Xiang (Автор), Ying-Ying Wang (Автор), Zi-Jun Wu (Автор), Jun-Ting Cheng (Автор), Jia-Fu Ji (Автор), Ji-Xin Zhong (Автор), Bo-Xu Ren (Автор), Xian-Wang Wang (Автор), Hong-Wu Xin (Автор)
Формат:
Опубликовано: Taylor & Francis Group, 2018-01-01T00:00:00Z.
Предметы:
Online-ссылка:Connect to this object online.
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Internet

Connect to this object online.

3rd Floor Main Library

Подробно о фондах из 3rd Floor Main Library
Шифр: A1234.567
Копировать 1 Доступно